The Middleby Corporation MIDD
122.73 USD -0.74 (-0.60%)
At closeNov 3, 2026, 4:03 PM EST
122.73 0.00 0.00%
After hours · Nov 3, 4:03 PM ET
121.53 Day range 124.42
89.16 52-week range 148.55
- YTD
- +2.61%
- 1 year
- +24.62%
Analyst view
Consensus: buy
Buy
Price target (mean) 154.78 +26.1% upside
Now 122.73
- Target (low)
- 145.00
- Target (mean)
- 154.78
- Target (high)
- 169.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
- Strong buy2
- Buy7
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.75 | 1.69 – 1.80 | 2.37 | -26.4% | 634.03M | -35.4% | 10 |
| Next quarter | 1.79 | 1.74 – 1.86 | 2.42 | -26.0% | 630.96M | -27.2% | 10 |
| Current year | 6.82 | 6.70 – 6.94 | 9.27 | -26.4% | 2.51B | -21.6% | 11 |
| Next year | 7.78 | 7.41 – 8.16 | 6.82 | +14.0% | 2.61B | +3.9% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 15, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 1, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 12, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 12, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 20, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Jefferies | Maintained | Buy | Buy |
| Jun 17, 2026 | Oppenheimer | Initiated | — | Outperform |
| Jun 15, 2026 | Jefferies | Maintained | Buy | Buy |
| May 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 10, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 27, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Feb 27, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 24, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 14, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Dec 10, 2025 | Jefferies | Upgrade | Hold | Buy |
| Dec 5, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 11, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 7, 2025 | JP Morgan | Upgrade | Underweight | Neutral |
| Oct 20, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 14, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Sep 4, 2025 | Wolfe Research | Initiated | — | Outperform |
| Sep 2, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
